Job van Exel
List of publications
van Hezik-Wester, V., de Groot, S., Kanters, T., Wagner, L., Ardesch, J., Brouwer, W., Corro-Ramos, I., van Exel, J. and Versteegh, M. (2024). The Cost-Effectiveness of Seizure Dogs for Persons Living With Severe Refractory Epilepsy: Results From the EPISODE Study Value in Health, :.
Bom, JudithA.M., Voormolen, DaphneC., Brouwer, WernerB.F., de Bekker-Grob, EstherW. and van Exel, J. (2024). Construct Validity, Reliability, and Responsiveness of the 10-Item Well-being Instrument for Use in Economic Evaluation Studies Value in Health, 27(7):871--878.
Mouter, N., Boxebeld, S., Kessels, R., van Wijhe, M., de Wit, A., Lambooij, M. and van Exel, J. (2022). Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands Value in Health, 25(8):1290--1297.
Himmler, S., Soekhai, V., van Exel, J. and Brouwer, W. (2021). What works better for preference elicitation among older people? Cognitive burden of discrete choice experiment and case 2 best-worst scaling in an online setting Journal of Choice Modelling, 38:.
Pleeging, E., van Exel, J., Burger, M. and Stavropoulos, S. (2021). Hope for the future and willingness to pay for sustainable energy Ecological Economics, 181:.
Reckers-Droog, V., van Exel, N. and Brouwer, W. (2021). Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients Value in Health, :.
EPISODE-team, , Wester, V., de Groot, S., Versteegh, M., Kanters, T., Wagner, L., Ardesch, J., Brouwer, W. and van Exel, J. (2021). Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy Value in Health, 24(10):1470--1475.
Baji, P.(., Farkas, M., Golicki, D., Rupel, V., Hoefman, R., Brouwer, W., van Exel, J., Zrubka, Z., Gulacsi, L. and Pentek, M. (2020). Development of population tariffs for the CarerQol instrument for Hungary, Poland and Slovenia: a discrete choice experiment study to measure the burden of informal caregiving Pharmacoeconomics (Print), 38(6):633--643.
Bijlmakers, L., Baltussen, R.(., Jansen, M., Boer, B., Helderman, J.(., Groenewoud, A.(., Zwaap, J., Van Dijk, W. and van Exel, J. (2020). Increasing the legitimacy of tough choices in health care: approach and results of a citizen forum in The Netherlands Value in Health, 23(1):32--38.
Himmler, S., van Exel, J. and Brouwer, W. (2020). Estimating the monetary value of health and capability well?being applying the well?being valuation approach The European Journal Of Health Economics, 21:1235--1244.
Himmler, S., van Exel, J., Perry-Duxbury, M. and Brouwer, W. (2020). Willingness to pay for an early warning system for infectious diseases. The European Journal Of Health Economics, 21:763--773.
Neumann - Boehme, S., Varghese, N., Sabat, I., Barros, P.P., Brouwer, W., van Exel, J., Schreyögg, J. and Stargardt, T. (2020). Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 The European Journal Of Health Economics, 21:977--982.
Rotteveel, A., Lambooij, M.(., Zuithoff, N., van Exel, J., Moons, K.(. and de Wit, G.(. (2020). Valuing healthcare goods and services: A systematic review and meta-analysis on the WTA-WTP disparity Pharmacoeconomics (Print), 38:443--458.
Brouwer, W.B.F., van Baal, P.H.M., van Exel, N.J.A. and Versteegh, M.M. (2019). When is it too expensive? Cost-effectiveness thresholds and health care decision making The European Journal Of Health Economics, 20(2):175--180.
Gheorghe, M., Hoefman, R., Versteegh, M. and van Exel, J. (2019). Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool Pharmacoeconomics (Print), 37(1):93--103.
Huls, S., Whichello, C.L., van Exel, J., Uyl - de Groot, C. and de Bekker - Grob, E. (2019). What Is Next for Patient Preferences in Health Technology Assessment? A Systematic Review Value in Health, 22(11):1318--1328.
Perry-Duxbury, M., van Exel, J., Brouwer, W., Skoldunger, A., Gonçalves-Pereira, M., Irving, K., Meyer, G., Selbaek, G., Woods, B., Zanetti, O., Verhey, F., Wimo, A. and Handels, R. (2019). How to value safety in economic evaluations in health care? A review of applications in different sectors The European Journal Of Health Economics, 20(7):1041--1061.
Reckers - Droog, V., van Exel, J. and Brouwer, W. (2019). Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both? Value in Health, 22(12):1441--1449.
Hoefman, R., van Exel, J. and Brouwer, W. (2019). The monetary value of informal care: obtaining pure time valuations using a Discrete Choice Experiment Pharmacoeconomics (Print), 37(4):531--540.
Mason, H., Collins, M., McHugh, N., Godwin, J., van Exel, J., Donaldson, C. and Baker, R. (2018). Is 'end of life' a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments Health Economics, 27(5):819--831.
van Nooten, F.(., van Busschbach, J., Agthoven, M., van Exel, J. and Brouwer, W. (2018). What should we know about the person behind a TTO? The European Journal Of Health Economics, 19(9):1207--1211.
Verbooy, K., Hoefman, R., van Exel, J. and Brouwer, W. (2018). Time is money: Investigating the value of leisure time and unpaid work Value in Health, 21(12):1428--1436.
Hackert, M., van Exel, J. and Brouwer, W. (2017). Valid Outcome Measures in Care for Older People: Comparing the ASCOT and ICECAP-O Value in Health, 20(7):936--944.
Hoefman, R., van Exel, J. and Brouwer, W. (2017). Measuring care-related quality of life of caregivers for use in economic evaluations: CarerQol tariffs for Australia, Germany, Sweden, the UK and the US Pharmacoeconomics (Print), 35(4):469--478.
Rappange, D., van Exel, J. and Brouwer, W. (2017). A short note on measuring subjective life expectancy: Survival probabilities versus point estimates The European Journal Of Health Economics, 18(1):7--12.
Soeteman, L., van Exel, J. and Bobinac, A. (2017). The impact of the design of payment scales on the willingness to pay for health gains The European Journal Of Health Economics, 18(6):743--760.
Wetering, L., van Exel, J. and Brouwer, W. (2017). The risk of conditional reimbursement: Stopping reimbursement can be more difficult than not starting in the first place! Value in Health, 20(1):118--125.
van Nooten, F.(., Brouwer, W., van Exel, J., Houghton, K., van Agthoven, M.(. and Stull, D. (2017). A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises Value in Health, 20(10):1403--1410.
Wouters, S., van Exel, J., Baker, R. and Brouwer, W. (2017). Priority to end of life treatments? Views of the public in the Netherlands. Value in Health, 20(1):107--117.
Al-Janabi, H., van Exel, J., Brouwer, W., Trotter, C., Glennie, L., Hannigan, L. and Coast, J. (2015). Measuring health spillovers for economic evaluation: A case study in meningitis Health Economics, 25(12):1529--1544.
Wetering, L., van Exel, J. and Brouwer, W. (2016). Health or Happiness? A note on the relative value of health and happiness in rationing decisions Value in Health, 19(5):552--557.
Garrido-García, S., Sánchez-Martínez, F.I., Abellán-Perpiñán, J.M. and Van Exel, J. (2015). Monetary Valuation of Informal Care Based on Carers' and Noncarers' Preferences Value in Health, 18(6):832--840.
Krol, M., Papenburg, J. and van Exel, J. (2015). Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies Pharmacoeconomics (Print), 33(2):123--135.
Wetering, L., van Exel, J., Bobinac, A. and Brouwer, W. (2015). Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment Pharmacoeconomics (Print), 33:1289--1300.
Wouters, S., van Exel, J., van den Donk, M., Rohde, K. and Brouwer, W. (2015). Do people desire to be healthier than other people? A short note on positional concerns for health The European Journal Of Health Economics, 16(1):47--54.
Attema, A., Brouwer, W. and van Exel, J. (2013). Your right arm for a publication in AER? Economic Inquiry, 52(1):495--502.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2014). The value of a QALY: Individual willingness to pay for health gains under risk Pharmacoeconomics (Print), 32:75--86.
Péntek, M, Gulácsi, L, Rojkovich, B, Brodszky, V, van Exel, N.J.A. and Brouwer, W.B.F. (2014). Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists The European Journal Of Health Economics, 15(S1):83--92.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2013). Valuing QALY gains by applying a societal perspective Health Economics, 22:1272--1281.
Hoefman, R., van Exel, J. and Brouwer, W. (2013). How to include informal care in economic evaluations Pharmacoeconomics (Print), 31(12):1105--1119.
Wetering, L., Stolk, E., van Exel, J. and Brouwer, W. (2013). Balancing equity and efficiency in the Dutch basis benefits package using the principle of proportional shortfall The European Journal Of Health Economics, 14:107--115.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2012). GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation Journal of Health Economics, 31:158--168.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2012). Inquiry into the Relationship between Equity Weights and the Value of the QALY Value in Health, 15:1119--1126.
Tilling, C.(., Krol, M., Tsuchiya, A., Brazier, J., van Exel, J. and Brouwer, W. (2012). Does the EQ-5D Reflect Lost Earnings? Pharmacoeconomics (Print), 1(30):47--61.
Bobinac, A., Brouwer, W. and van Exel, J. (2011). Discounting future health gains: an empirical enquiry into the influence of growing life expectancy Health Economics, 20:111--119.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2010). Caring for and caring about: Disentangling the caregiver effect and the family effect Journal of Health Economics, 29:549--556.
Bobinac, A., van Exel, J., Rutten, F. and Brouwer, W. (2010). Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective Value in Health, 13(8):1049--1055.
de Meijer, C.(., Brouwer, W., Koopmanschap, M., van den Berg, B.(. and van Exel, J. (2010). The value of informal care-A further investigation of the feasibility of contingent valuation in informal caregivers Health Economics, 19:755--771.
Wetering, L., van Exel, J. and Brouwer, W. (2010). Piecing the jigsaw puzzle of adolescent happiness Journal of Economic Psychology, 31:923--935.
van Exel, J. and Rietveld, P. (2009). Could you also have made this trip by another mode? An investigation of perceived travel possibilities of car and train travellers on the main travel corridors to the City of Amsterdam, The Netherlands Transportation Research. Part A, Policy and Practice, 43(4):374--385.
van Exel, J. and Rietveld, P. (2009). When strike comes to town...anticipated and actual behavioural reactions to a one-day, pre-announced, complete rail strike in the Netherlands. Transportation Research. Part A, Policy and Practice, 43(5):526--535.
Brouwer, W.B.F., van Exel, N.J.A., Baker, R. and Donaldson, C. (2008). The New Myth The Social Value of QUALY Pharmacoeconomics (Print), 26(1):1--4.
Brouwer, W., Culyer, A., van Exel, J. and Rutten, F. (2008). Welfarism vs. extra-welfarism Journal of Health Economics, 27:325--338.
Koopmanschap, M., van Exel, J., van den Berg, B.(. and Brouwer, W. (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare Pharmacoeconomics (Print), 26(4):269--280.
Rappange, D., van Baal, P., Rutten, F., van Exel, J., Feenstra, T.(. and Brouwer, W. (2008). Unrelated medical costs in life-years gained should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics (Print), 26(10):815--860.
van den Berg, B., Al, M., van Exel, J., Koopmanschap, M. and Brouwer, W. (2008). Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers Value in Health, 11(7):1041--1050.
Brouwer, W., Van Exel, J., Baker, R. and Donaldson, C. (2008). The new myth: The Social Value of the QALY Pharmacoeconomics (Print), 26(1):1--4.
van Exel, J., Brouwer, W., van den Berg, B.(. and Koopmanschap, M. (2006). With a little help from an anchor; Discussion and evidence of anchoring effects in contigent valuation Journal of Socio-economics, 35:836--853.
Brouwer, W., van Exel, J., Baltussen, R.(. and Rutten, F. (2006). A Dollar is a Dollar Is a Dollar - or Is It? Value in Health, 9(5):341--347.
van der Berg, B.(., Brouwer, W., van Exel, J. and Koopmanschap, M. (2005). Economic valuation of informal care: the contingent valuation method applied to informal caregiving Health Economics, 14(2):169--183.
Polinder, S., Meerding, W.(.J., van Exel, J. and Brouwer, W. (2005). Societal discounting of health effects in cost-effectiveness analyses - The influence of life expectancy Pharmacoeconomics (Print), 23(8):791--802.
van Exel, J., Rienstra, S., Gommers, M., Pearman, A. and Tsamboulas, D. (2002). EU involvement in TEN development: network effects and European value added Transport Policy, 9:299--311.
Van Exel, N.JobA. and Rietveld, P. (2001). Public transport strikes and traveller behaviour Transport Policy, 8(4):237--246.